Vista previa | Fecha de publicación | Título | Autor(es) | Acceso |
![Aplicación del programa de reducción del estrés basado en atencion plena Psicología Conductual 2022 ingles.pdf.jpg](/retrieve/cbdf97b8-7e62-47a7-a132-d6cdb710c55a/Aplicaci%c3%b3n%20del%20programa%20de%20reducci%c3%b3n%20del%20estr%c3%a9s%20basado%20en%20atencion%20plena%20Psicolog%c3%ada%20Conductual%202022%20ingles.pdf.jpg) | 2022 | Application of the Mindfulness-Based Stress Reduction program to patients with borderline personality disorder and chronic pain: A pilot study | Verdú García, María Luisa; QUILES, YOLANDA | ![](/image/closedAccess.png) |
![Association between chronic pain medications.pdf.jpg](/retrieve/d3b43b36-3681-43bf-8658-45f8cb5d5815/Association%20between%20chronic%20pain%20medications.pdf.jpg) | jul-2021 | Association between chronic pain medications and the severity and mortality of COVID-19: Study protocol for a case-population study | Serrano Afonso, Ancor; Pérez hernández, Concepción; Ochoa Mazarro, Dolores; Román Martínez, Manuel; Failde Martínez, Inmaculada; Montes Pérez, Antonio; López Pais, Pablo; Cánovas Martínez, Luz; Revuelta Rizo, Miren; Padilla del Rey, María Luz; Peiró, Ana; Aberasturi Fueyo, Teresa; Margarit Ferrí, César; Rojo Rodríguez, Elena; Mendiola de la Osa, Agustín; Muñoz Martinez, Manuel José; Domínguez Bronchal, María Jesús; Herrero Trujillano, Manuel; Cid Calzada, José; Fabregat-Cid, Gustavo; Hernández-Cádiz, María José; Mareque Ortega, Manuel; Gómez-Caro Álvarez Palencia, Leticia; Mayoral Rojals, Víctor | ![](/image/openAccess.png) |
![Clinical prediction of opioid use disorder in chronic pain patients. A cohort-retrospective study with a pharmacogenetic approach.pdf.jpg](/retrieve/a558ddfe-37b5-4dd4-8872-0167dd3ecf23/Clinical%20prediction%20of%20opioid%20use%20disorder%20in%20chronic%20pain%20patients.%20A%20cohort-retrospective%20study%20with%20a%20pharmacogenetic%20approach.pdf.jpg) | 12-abr-2024 | Clinical prediction of opioid use disorder in chronic pain patients: a cohort-retrospective study with a pharmacogenetic approach | Escorial, Mónica; Muriel, Javier; Agulló, Laura; Zandonai, Thomas; Margarit, César; Morales, Domingo; Peiró, Ana | ![](/image/openAccess.png) |
![CYP2D6 phenotypes and opioid metabolism. the path to personalised analgesia.pdf.jpg](/retrieve/8a3fbbc5-ffc9-46b8-b233-5a18818cb254/CYP2D6%20phenotypes%20and%20opioid%20metabolism.%20the%20path%20to%20personalised%20analgesia.pdf.jpg) | abr-2022 | CYP2D6 phenotypes and opioid metabolism: the path to personalized analgesia | Ballester, Purificación; Muriel, Javier; Peiró, Ana | ![](/image/closedAccess.png) |
![TFG-Espadas Ramírez, Patricio.pdf.jpg](/retrieve/19553d18-e260-4c82-a890-ed7563f380f8/TFG-Espadas%20Ram%c3%adrez%2c%20Patricio.pdf.jpg) | sep-2022 | Descripción de un proceso de intervención en la línea de atención psicosocial de Cruz Roja Española “Cruz Roja Te Escucha” | Espadas Ramírez, Patricio | ![](/image/openAccess.png) |
![TFG CRISTIAN HERNÁNDEZ CALLADO.pdf.jpg](/retrieve/e4e4d07c-2a17-4aa0-9c9a-2e3d988c39f6/TFG%20CRISTIAN%20HERN%c3%81NDEZ%20CALLADO.pdf.jpg) | 21-jun-2021 | Efectividad de la educación en neurociencia del dolor en pacientes con dolor crónico | Hernández Callado, Cristian | ![](/image/openAccess.png) |
![Epigenetic and sex differences in opioid use disorder in chronic.pdf.jpg](/retrieve/1feefe51-464c-466d-91b0-38702c302af8/Epigenetic%20and%20sex%20differences%20in%20opioid%20use%20disorder%20in%20chronic.pdf.jpg) | 4-jun-2024 | Epigenetic and sex differences in opioid use disorder in chronic pain: A real-world study linked with OPRM1 DNA methylation | Agulló, Laura; Escorial, Mónica; Orutño, Samantha; Muriel, Javier; Sandoval, Juan; Margarit, César; Peiró, Ana | ![](/image/openAccess.png) |
![Impact of CYP2D6 genotype on opioid use disorder deprescription an observational prospective study in chronic pain with sex-differences.pdf.jpg](/retrieve/ff607586-26c5-4511-a50c-c94782d71227/Impact%20of%20CYP2D6%20genotype%20on%20opioid%20use%20disorder%20deprescription%20an%20observational%20prospective%20study%20in%20chronic%20pain%20with%20sex-differences.pdf.jpg) | 2023 | Impact of CYP2D6 genotype on opioid use disorder deprescription: an observational prospective study in chronic pain with sex-differences | Muriel, Javier; Barrachina, Jordi; Del Barco, Guillermo; Carvajal, Cristian; Escorial, Mónica; Margarit, César; Ballester, Purificación; Peiró, Ana María | ![](/image/openAccess.png) |
![Long-term deprescription in chronic pain and opioid use disorder patients. Pharmacogenetic and sex differences.pdf.jpg](/retrieve/442d251d-8781-4a09-b495-e3bbda10e4df/Long-term%20deprescription%20in%20chronic%20pain%20and%20opioid%20use%20disorder%20patients.%20Pharmacogenetic%20and%20sex%20differences.pdf.jpg) | 18-nov-2022 | Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences | Muriel, Javier; Escorial, Mónica; Margarit, César; Barrachina, Jordi; Carvajal, Cristian; Morales, Domingo; Peiró, Ana | ![](/image/openAccess.png) |
![5-OA-Published manuscript-JCM (1).pdf.jpg](/retrieve/6eb07510-de9c-4d78-b9f5-9f39be67d266/5-OA-Published%20manuscript-JCM%20%281%29.pdf.jpg) | nov-2021 | Motivational Determinants of Objective Physical Activity in
Women with Fibromyalgia Who Attended
Rehabilitation Settings | Pastor-Mira, María Ángeles; López Roig, Sofía; Martínez-Zaragoza, Fermín; Toribio, Eva; Nardi-Rodríguez, Ainara; Peñacoba, Cecilia | ![](/image/openAccess.png) |
![Opioid Monitoring in Clinical Settings Strategies and Implications.pdf.jpg](/retrieve/faac4598-625c-42f5-953a-37df0467ddb5/Opioid%20Monitoring%20in%20Clinical%20Settings%20Strategies%20and%20Implications.pdf.jpg) | 29-may-2024 | Opioid Monitoring in Clinical Settings: Strategies and Implications of Tailored Approaches for Therapy | Rosendo, Luana M.; Rosado, Tiago; Zandonai, Thomas; Rincon, Karem; Peiró, Ana; Barroso, Mário; Gallardo, Eugenia | ![](/image/openAccess.png) |
![OPRM1 influence on and effectiveness of an individualized.pdf.jpg](/retrieve/f0912f0d-190d-4252-9401-6e74eb01cbdc/OPRM1%20influence%20on%20and%20effectiveness%20of%20an%20individualized.pdf.jpg) | 2018 | OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients | Muriel, Javier; Margarit, César; Planelles, Beatriz; Serralta, María J.; Puga, Carmen; Inda, María del Mar; Cutillas, Esperanza; Morales, Domingo; Horga, José F. | ![](/image/closedAccess.png) |
![OPRM1 influence on and effectiveness of an individualized.pdf.jpg](/retrieve/2da87291-5d23-4d1f-88b1-3db1c6061462/OPRM1%20influence%20on%20and%20effectiveness%20of%20an%20individualized.pdf.jpg) | ago-2018 | OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients | Muriel, Javier; Margarit, César; Planelles, Beatriz; Serralta, María J.; Puga, Carmen; Inda, María del Mar; Cutillas, Esperanza; Morales, Domingo; Horga, José Francisco; Peiró, Ana | ![](/image/openAccess.png) |
![Pharmacogenetic Guided Opioid Therapy Improves Chronic.pdf.jpg](/retrieve/1772878b-270e-4cd7-bc03-a7cb5fee6471/Pharmacogenetic%20Guided%20Opioid%20Therapy%20Improves%20Chronic.pdf.jpg) | 2023 | Pharmacogenetic Guided Opioid Therapy Improves Chronic Pain Outcomes and Comorbid Mental Health: A Randomized, Double-Blind, Controlled Study | Agulló, Laura; Aguado, Isidro; Muriel, Javier; Margarit, César; Gómez, Alba; Escorial, Mónica; Sánchez, Astrid; Fernández, Alicia; Peiró, Ana | ![](/image/openAccess.png) |
![Pharmacogenetics and prediction of adverse events in.pdf.jpg](/retrieve/57275c95-8b6e-4e03-a7db-9b305d1d5d13/Pharmacogenetics%20and%20prediction%20of%20adverse%20events%20in.pdf.jpg) | 2018 | Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patients | Muriel, Javier; Margarit, César; Barrachina, Jordi; Ballester, Purificación; Flor, Andrea; Morales, Domingo; Horga, José F.; Fernández, Eduardo; Peiró, Ana | ![](/image/closedAccess.png) |
![4º APORTACIÓN 2020.pdf.jpg](/retrieve/cae11edc-bb23-4057-b1b0-14ff70a61cd5/4%c2%ba%20APORTACI%c3%93N%202020.pdf.jpg) | 16-jun-2020 | Promoting unsupervised walking in women with fibromyalgia: a randomized controlled trial | Pastor-Mira, María Ángeles; López Roig, Sofía; Martínez-Zaragoza, Fermín; Lledó, Ana; Lilian, Velasco; León-Zarceño, Eva; ECIJA-GALLARDO, Carmen; Peñacoba, Cecilia | ![](/image/closedAccess.png) |
![Sex Differences in Opioid Response Linked to OPRM1 and COMT genes DNA Methylation-Genotypes Changes in Patients with Chronic Pain.pdf.jpg](/retrieve/ea9a64a5-72c7-4efd-b163-0458923f5c5e/Sex%20Differences%20in%20Opioid%20Response%20Linked%20to%20OPRM1%20and%20COMT%20genes%20DNA%20Methylation-Genotypes%20Changes%20in%20Patients%20with%20Chronic%20Pain.pdf.jpg) | 13-may-2023 | Sex Differences in Opioid Response Linked to OPRM1 and COMT genes DNA Methylation/Genotypes Changes in Patients with Chronic Pain | Agulló, Laura; Muriel, Javier; Margarit, César; Escorial, Mónica; Garcia, Diana; Herrero, María José; Hervás, David; Sandoval, Juan; Peiró, Ana | ![](/image/openAccess.png) |
![Sex Differences in Oxycodone Naloxone vs. Tapentadol in Chronic Non-Cancer Pain. An Observational Real-World Study.pdf.jpg](/retrieve/a32f4d7a-81ff-4222-8a14-e364812dcd50/Sex%20Differences%20in%20Oxycodone%20Naloxone%20vs.%20Tapentadol%20in%20Chronic%20Non-Cancer%20Pain.%20An%20Observational%20Real-World%20Study.pdf.jpg) | 2-oct-2022 | Sex Differences in Oxycodone/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study | Barrachina, Jordi; Margarit, Cesar; Muriel, Javier; López Gil, Vicente; López Gil, Santiago; Ballester, Purificación; Mira-Lorente, Laura; Agulló, Laura; Peiró, Ana | ![](/image/openAccess.png) |
![TFG definitivo.pdf.jpg](/retrieve/9c3f2269-b6ad-49ed-937a-689041600c90/TFG%20definitivo.pdf.jpg) | 21-jun-2021 | Variables psicosociales implicadas en la cronificación del dolor | Pozo Escalona, Lucía | ![](/image/openAccess.png) |